| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3383866 | Reumatología Clínica | 2006 | 5 Pages |
Abstract
The use of ozone therapy in musculoskeletal diseases is based on poor quality studies. Currently, data supporting an adequate risk/benefit ratio for ozone therapy in rheumatic diseases is lacking.
Related Topics
Health Sciences
Medicine and Dentistry
Immunology, Allergology and Rheumatology
Authors
Loreto Carmona,